IP Verse

Merial, Inc. opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Aug 17, 2022

Title:

Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof

Oppositions:

Patent:

Grant Date:

Nov 3, 2021

Title:

Newcastle Disease Virus Vectored Avian Vaccines

Oppositions:

Patent:

Grant Date:

Mar 10, 2021

Title:

Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof

Oppositions:

Patent:

Grant Date:

Nov 21, 2018

Title:

Vaccine Against Streptococci

Oppositions:

Patent:

Grant Date:

Dec 27, 2017

Title:

Method Of Providing Protective Immunity Against Heterologous Leptospira Strains

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP2785374	Aug 17, 2022	Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof	1
EP2998315	Nov 3, 2021	Newcastle Disease Virus Vectored Avian Vaccines	1
EP3061454	Mar 10, 2021	Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof	2
EP3167900	Nov 21, 2018	Vaccine Against Streptococci	1
EP2874653	Dec 27, 2017	Method Of Providing Protective Immunity Against Heterologous Leptospira Strains	1

INTERVET INTERNATIONAL B.V.

AWA SWEDEN AB

INTERVET INTERNATIONAL BV

Feel free to send us a message here and we will get back to you